Accelerating drug development for neuroblastoma - New Drug Development Strategy: an ITCC, ENCCA and Adolescents and SIOPEN project
Previous
Previous
Image-defined risk factors in unresectable neuroblastoma: SIOPEN study on incidence, chemotherapy-induced variation, and impact on surgical outcomes
Next
Next